Mallinckrodt Agrees to Buy Questcor for $5.6 Billion

Mallinckrodt Plc agreed to buy Questcor Pharmaceuticals Inc. for $5.6 billion to add specialty drugs in the latest industry deal that moves a U.S. company to Ireland for a lower tax rate.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.